Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Akwaaba Mining Ltd. Proxy Solicitation & Information Statement 2025

Jan 30, 2025

46474_rns_2025-01-30_1acf66d1-e9a2-4a45-ba49-c6e78b9eba96.pdf

Proxy Solicitation & Information Statement

Open in viewer

Opens in your device viewer

January 29, 2025

Filed via SEDAR+

TO: ALL APPLICABLE EXCHANGES AND COMMISSIONS:

Subject: Helix Biopharma Corp. Notice of Record and Meeting Dates

We advise the following with respect to the upcoming Annual General and Special Meeting of Security Holders for the subject issuer:

  1. CUSIP Number
    ISIN Number: 422910208
    CA4229102088

  2. Meeting Type: Annual & Special

  3. Record Date: 31-Jan-2025 (Amended)

  4. Beneficial Ownership Date: 31-Jan-2025 (Amended)

  5. Mail Date: 24-Feb-2025 (Amended)

  6. Meeting Date: 26-Mar-2025 (Amended)

  7. Classes or Series of Securities that entitle the holder to receive Notice of the Meeting: COMMON

  8. Classes or Series of Securities that entitle the holder to vote at the meeting: COMMON

  9. Business to be conducted at the meeting: Annual & Special

  10. Notice-and-Access:

  11. Registered Shareholders: Yes
  12. Beneficial Holders: Yes
  13. Stratification Level: Not Applicable
  14. E-Delivery: Yes

  15. Reporting issuer is sending proxy-related Materials directly to Non-Objecting Beneficial Owners: No (Amended)

  16. Issuer paying for delivery to Objecting Beneficial Owners: No

  17. Issuer paying for delivery to US Non-Objecting Beneficial Owners: No

In accordance with applicable securities regulations, we are filing this information with you directly on behalf of the Issuer.

Sincerely,

HELIX BIOPHARMA CORP.

Suite 2704-401 Bay Street

Toronto, ON M5H 2Y2